Maxim Group analyst Anthony Vendetti reiterated a Buy rating on Venus Concept (VERO – Research Report) yesterday and set a
Category: Healthcare
Acorda Therapeutics (ACOR) Receives a Buy from Cowen & Co.
Cowen & Co. analyst Phil Nadeau reiterated a Buy rating on Acorda Therapeutics (ACOR – Research Report) on January 13
Oppenheimer Keeps Their Buy Rating on Viking Therapeutics (VKTX)
Oppenheimer analyst Jay Olson maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price
Oppenheimer Maintains a Hold Rating on Nektar Therapeutics (NKTR)
Oppenheimer analyst Jay Olson maintained a Hold rating on Nektar Therapeutics (NKTR – Research Report) today and set a price
Needham Thinks Esperion’s Stock is Going to Recover
Needham analyst Chad Messer reiterated a Buy rating on Esperion (ESPR – Research Report) today and set a price target
Abbott Labs (ABT) Receives a Hold from BTIG
In a report released today, Marie Thibault from BTIG maintained a Hold rating on Abbott Labs (ABT – Research Report).
William Blair Remains a Buy on Karuna Therapeutics (KRTX)
William Blair analyst Myles Minter reiterated a Buy rating on Karuna Therapeutics (KRTX – Research Report) today. The company’s shares